Product
Levocarnitine
Name
Levocarnitine
INN Name
Levocarnitine
FDA Approved
Yes
2 clinical trials
9 organizations
4 indications
3 documents
Indication
Dry Eye SyndromeIndication
Acute Lymphoblastic LeukemiaIndication
Liver DamageIndication
Sjögren's syndromeClinical trial
A Randomized Placebo-controlled, Double Blind Pilot Crossover Trial of Levocarnitine for the Treatment of Keratoconjunctivitis Sicca in Sjogren's SyndromeStatus: Recruiting, Estimated PCD: 2025-03-01
Clinical trial
Use of Levocarnitine to Reduce Asparaginase Hepatotoxicity in Patients With Acute Lymphoblastic LeukemiaStatus: Recruiting, Estimated PCD: 2023-12-31
Organization
Rising Pharmaceuticals, Inc.Document
DailyMed Label: Carnitor SFDocument
DailyMed Label: CARNITOROrganization
Leadiant Biosciences, Inc.Organization
TRUPHARMA, LLCOrganization
Hikma Pharmaceuticals USA Inc.Document
DailyMed Label: LevocarnitineOrganization
Akorn - Strides LLC Organization
ANI Pharmaceuticals, Inc.Organization
American Regent, Inc.Organization
Rising Pharma Holdings, Inc.Organization
Saptalis Pharmaceuticals, LLC.